Cardinal Health Inc. closed 5.54% short of its 52-week high of $139.50, which the company achieved on April 3rd.

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The research service ...

Cardinal Health (CAH) closed the latest trading day at $128.88, indicating a -1.2% change from the previous session's end. The stock's performance was ahead of the S&P 500's daily loss of 3.46%.

Cardinal is using its own cyclotron installations to produce Gozellix for distribution across a range of US locations.

The stock's rise snapped a four-day losing streak.

Telix Pharmaceuticals TLX recently announced a major step in expanding access to its next-generation prostate cancer imaging ...

Following recent U.S. Food and Drug Administration (FDA) approval 2, and in preparation for commercial launch in H1 2025, Telix has contracted with Cardinal Health to enable availability across a wide ...

This was the stock's third consecutive day of losses.

The medical supplies industry is at a turning point, driven by rising demand for home-based care and advancing technology to meet evolving patient and provider expectations.

Quarterly financial reports play a vital role on Wall Street, as they help investors see how a company has performed and what might be coming down the road in the near-term. And out of all of the ...

Two years after Lauren Betts transferred from Stanford, the junior center spoke about her negative experience with the ...